Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulation for PA-HSOS
ChiCTR-IPR-17010784Phase 4Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Mar 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of warfarin and low molecular weight heparin calcium in hepatic veno-occlusive disease (HVOD) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: PA-HSOS Gulou scoring criteria. Started Mar 2017; status: recruiting.
02
Drugs
warfarinlow molecular weight heparin calcium
03
Conditions
hepatic veno-occlusive disease (HVOD)
Beyond the preview
Go deeper on ChiCTR-IPR-17010784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010784.